MicroRNA-145 Mediates the Formation of Angiotensin II-Induced Murine Abdominal Aortic Aneurysm

Heart Lung and Circulation

Volumn 26, Issue 6, 2017, Pages 619-626

  Wu, Jing ^a   Wang, Jun ^c   Li, Xiaoou ^d   Liu, Xiaofeng ^d   Yu, Xiuyan ^d   Tian, Yunling ^b  

^a GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^b LANZHOU UNIVERSITY   (China)

^c Shenzhen Center for the Disease Control and Prevention   (China)

^d Tumor Hospital of Jilin Province   (China)

Author keywords

Aneurysm; MicroRNA 145; MMP2

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; COLLAGEN; ELASTIN; GELATINASE A; MICRORNA 145; MICRORNA; MIRN145 MICRORNA, MOUSE; MMP2 PROTEIN, MOUSE;

ABDOMINAL AORTIC ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LENTIVIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; GENETIC TRANSDUCTION; GENETICS; KNOCKOUT MOUSE; LENTIVIRUS; METABOLISM; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; COLLAGEN; DISEASE MODELS, ANIMAL; ELASTIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LENTIVIRUS; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; MICRORNAS; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 85008224779     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2016.10.009     Document Type: Article

References (27)

1. [1] Satoh, K., Nigro, P., Matoba, T., O'Dell, M.R., Cui, Z., Shi, X., et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med. 15 (2009), 649–656.
2. [2] Stather, P.W., Sidloff, D.A., Dattani, N., Gokani, V.J., Choke, E., Sayers, R.D., et al. Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg. 101 (2014), 1358–1372.
3. [3] Vorp, D.A., Vande Geest, J.P., Biomechanical determinants of abdominal aortic aneurysm rupture. Arterioscler Thromb Vasc Biol. 25 (2005), 1558–1566.
4. [4] Davis, F.M., Rateri, D.L., Daugherty, A., Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart. 100 (2014), 1498–1505.
5. [5] Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116 (2004), 281–297.
6. [6] Milewicz, D.M., MicroRNAs, fibrotic remodeling, and aortic aneurysms. J Clin Invest. 122 (2012), 490–493.
7. [7] Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D.Z., Lu, Q., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 105 (2009), 158–166.
8. [8] Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 100 (2007), 1579–1588.
9. [9] Wang, S., Zhang, C., Zhang, M., Liang, B., Zhu, H., Lee, J., et al. Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med. 18 (2012), 902–910.
10. [10] Maegdefessel, L., Azuma, J., Toh, R., Merk, D.R., Deng, A., Chin, J.T., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest. 122 (2012), 497–506.
11. [11] Sparks, A.R., Johnson, P.L., Meyer, M.C., Imaging of abdominal aortic aneurysms. Am Fam Physician. 65 (2002), 1565–1570.
12. [12] Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., et al. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res. 106 (2010), 1117–1128.
13. [13] Wang, S., Xu, J., Song, P., Wu, Y., Zhang, J., Chul Choi, H., et al. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension. 52 (2008), 484–490.
14. [14] Wang, Y.X., Martin-McNulty, B., da Cunha, V., Vincelette, J., Lu, X., Feng, Q., et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation. 111 (2005), 2219–2226.
15. [15] Wang, S., Peng, Q., Zhang, J., Liu, L., Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res. 80 (2008), 255–262.
16. [16] Wang, S., Xu, J., Song, P., Viollet, B., Zou, M.H., In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes. 58 (2009), 1893–1901.
17. [17] Zhang, J., Xie, Z., Dong, Y., Wang, S., Liu, C., Zou, M.H., Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. J Biol Chem. 283 (2008), 27452–27461.
18. [18] Lu, H., Rateri, D.L., Cassis, L.A., Daugherty, A., The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep. 10 (2008), 99–106.
19. [19] Daugherty, A., Cassis, L.A., Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 24 (2004), 429–434.
20. [20] Thomas, M., Gavrila, D., McCormick, M.L., Miller, F.J. Jr., Daugherty, A., Cassis, L.A., et al. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation. 114 (2006), 404–413.
21. [21] Pearce, W.H., Shively, V.P., Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann N Y Acad Sci. 1085 (2006), 117–132.
22. [22] Aziz, F., Kuivaniemi, H., Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg. 21 (2007), 392–401.
23. [23] Maegdefessel, L., Spin, J.M., Raaz, U., Eken, S.M., Toh, R., Azuma, J., et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nature Communications., 5, 2014, 5214.
24. [24] Maegdefessel, L., Azuma, J., Toh, R., Deng, A., Merk, D.R., Raiesdana, A., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Science Translational Medicine, 4, 2012 122ra22.
25. [25] Pei, H., Tian, C., Sun, X., Qian, X., Liu, P., Liu, W., et al. Overexpression of MicroRNA-145 Promotes Ascending Aortic Aneurysm Media Remodeling through TGF-b1. Eur J Vasc Endovasc Surg. 49 (2015), 52–59.
26. [26] Han, T., Yi, X.P., Liu, B., Ke, M.J., Li, Y.X., MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9. Molecular Medicine Reports. 11 (2015), 4115–4120.
27. [27] Yu, C.C., Tsai, L.L., Wang, M.L., Yu, C.H., Lo, W.L., Chang, Y.C., et al. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res. 73 (2013), 3425–3440.